Skip to content

Jobs updated Oct 23, 6:25 AM CT

COMPANY

SanBio Co Ltd

HQ: Tokyo, Japan source · sanbio.com ↗

Past trials only

Keywords: cell therapy biomanufacturing Chronic Ischemic Stroke Traumatic Brain Injury SB623 SB623 cells

Location: Tokyo, Japan · source · Oct 14, 2026

Profile checked Oct 10, 2026

3Trials (company is sponsor)

Timeline

Jul 6, 2016 Trial start Phase 2: A Study of Modified Stem Cells in Traumatic Brain Injury (TBI) source ↗
Mar 8, 2016 Trial start Phase 2: Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke source ↗
2011-01 Trial start Phase 1/Phase 2: A Study of Modified Stem Cells in Stable Ischemic Stroke source ↗

Clinical trials (lead sponsor) 3

Record	Title	Phase	Status	Start	Primary completion
NCT01287936	A Study of Modified Stem Cells in Stable Ischemic Stroke	Phase 1/Phase 2	Completed	2011-01	2015-08 (actual)
NCT02416492	A Study of Modified Stem Cells in Traumatic Brain Injury (TBI)	Phase 2	Completed	Jul 6, 2016	Jan 31, 2019 (actual)
NCT02448641	Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke	Phase 2	Completed	Mar 8, 2016	Dec 5, 2018 (actual)